Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Abstral 400 microgram sublingual tablets

Active Ingredient:
fentanyl citrate
Company:  
Grunenthal Meds See contact details
ATC code: 
N02AB03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Abstral - UK Patient and Carer guide

Important risk minimisation information, on Abstral (fentanyl citrate) sublingual tablet, for patients prescribed Abstral and their carers

{pdf_link}

Abstral - UK Pharmacist Guide

{healthcare_pro_orange} For Healthcare Professionals

Important risk minimisation information, on Abstral (fentanyl citrate) sublingual tablet, for pharmacists

{pdf_link}

Abstral - UK Prescriber Guide

{healthcare_pro_orange} For Healthcare Professionals

Important risk minimisation information, on Abstral (fentanyl citrate) sublingual tablet, for physicians

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Grunenthal Meds
Company image
Address
Grünenthal Meds, Kyowa Kirin International UK NewCo Ltd, Building 6, Galabank Business Park, Galashiels, Borders, TD1 1QH, UK
Telephone
+44 (0)1896 664 000
Medical Information Direct Line
+44 (0)1896 664 000
Medical Information e-mail
[email protected]
Stock Availability
+44 (0)1896 664 000
WWW
www.grunenthalmedshub.co.uk
Adverse event reporting email
[email protected]